APPLICATION
ANDA205031
TYPE
ANDA
ORIGINAL APPROVAL
2022-03-17
LATEST ACTION
2024-11-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
LACOSAMIDEPrescription
LACOSAMIDE 150MG · TABLET · ORAL
LACOSAMIDEPrescription
LACOSAMIDE 50MG · TABLET · ORAL
LACOSAMIDEPrescription
LACOSAMIDE 200MG · TABLET · ORAL
LACOSAMIDEPrescription
LACOSAMIDE 100MG · TABLET · ORAL
Approval history
2024-11-15Labeling · Supplement 3 · standardAP
2024-11-15Labeling · Supplement 10 · standardAP
2024-11-15Labeling · Supplement 2 · standardAP
2024-11-15Labeling · Supplement 5 · standardAP
2022-03-17UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.